Foam-Based Wound Stasis Technology Could Save Lives

Battlefield medical care administered by first responders is often critical to the survival of injured servicemembers. In the case of internal abdominal injuries and resulting internal hemorrhaging, however, there is currently little that can be done to stanch bleeding before the patients reach necessary treatment facilities. The resulting blood loss often leads to death from what would otherwise be potentially survivable wounds. A foam-based technology developed under DARPA's Wound Stasis System program has demonstrated encouraging results in testing. In test models, the foam has been shown to control hemorrhaging in a patient's intact abdominal cavity for at least one hour. During testing, application of the product reduced blood loss six-fold and increased the rate of survival at three hours post-injury to 72 percent from the eight percent observed in controls. The foam is designed to be administered on the battlefield by a combat medic, and is easily removable by doctors during surgical intervention at an appropriate facility.

Transcript

00:00:00 the Arsenal foam technology has been engineered to treat life-threatening non-compressible abdominal trauma this product shown here treating an acute liver injury is injected as two liquid phases upon mixing a chemical reaction is initiated causing the material to expand throughout the abdominal cavity making contact with ses of injury and creating a tonot effect to stop bleeding

00:00:26 the product mols to the anatomy allowing injured patients to be trans reported to surgical care where it can be removed